Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
PLoS One ; 17(10): e0275333, 2022.
Article in English | MEDLINE | ID: covidwho-2079743

ABSTRACT

BACKGROUND: The COVID-19 pandemic has exceeded 6 million known disease-related deaths and there is evidence of an increase in maternal deaths, especially in low- and middle-income countries. We aimed to estimate excess maternal deaths in Brazil and its macroregions as well as their trajectories in the first 15 months of the COVID-19 epidemic. METHODS: This study evaluated maternal deaths from the Mortality Information System of the Ministry of Health, with excess deaths being assessed between March 2020 and May 2021 by quasi-Poisson generalized additive models adjusted for overdispersion. Observed deaths were compared to deaths expected without the pandemic, accompanied by 95% confidence intervals according to region, age group, and trimester of occurrence. Analyses were conducted in R version 3.6.1 and RStudio version 1.2.1335. RESULTS: There were 3,291 notified maternal deaths during the study period, resulting in a 70% excess of deaths regardless of region, while in the North, Northeast, South and Southeast regions, excess deaths occurred regardless of age group. Excess deaths occurred in the March-May 2021 trimester regardless of region and age group. Excess deaths were observed in the Southeast region for the 25-36-year-old age group regardless of the trimester assessed, and in the North, Central-West and South regions, the only period in which excess deaths were not observed was September-November 2020. Excess deaths regardless of trimester were observed in the 37-49-year-old age group in the North region, and the South region displayed explosive behavior from March-May 2021, with a 375% excess of deaths. CONCLUSIONS: Excess maternal deaths, with geographically heterogenous trajectories and consistently high patterns at the time of the epidemic's greatest impact, reflect not only the previous effect of socioeconomic inequalities and of limited access to maternal health services, but most of all the precarious management of Brazil's health crisis.


Subject(s)
COVID-19 , Maternal Death , Female , Humans , Adult , Middle Aged , COVID-19/epidemiology , Pandemics , Brazil/epidemiology , Maternal Mortality , Mortality
2.
Cad Saude Publica ; 38(7): e00041922, 2022.
Article in Portuguese | MEDLINE | ID: covidwho-1993585

ABSTRACT

This ecological study evaluated the trajectory of COVID-19 mortality rates in Brazil and compared the extreme rates of 2022 and 2021, in different age groups. Data on deaths due to severe acute respiratory syndrome by COVID-19 were obtained from the Influenza Epidemiological Surveillance Information System. Deaths were evaluated from January 10, 2021 to February 12, 2022, grouped into Epidemiological Weeks (EW). Data analysis was conducted in the R software, using Poisson models to estimate mortality rates. Statistical significance level was set at 5%. A total of 408,180 deaths were evaluated, 0.34% of whom were under 18 years old, and 64.6% of whom were 60 years old and over. On the one hand, in the 0-1, 2-4 and 5-11 age groups, higher mortality rates were observed in EW 4-6/2022, compared to the higher ones in 2021. On the other, in the 12-17 age group, a lower rate was estimated in the EW 4-6/2022 group compared to the EW 11-13 group in 2021, with a mortality ratio of 0.60 (95%CI: 0.38-0.94). Opposing patterns were detected in COVID-19 mortality in Brazil among children and individuals included in the national vaccination campaign. Among the former, mortality rates equal to or worse than in previous phases of the epidemic were observed, contrasting with the consistent and strong decline registered in the latter, reinforcing the effectiveness of COVID-19 vaccines.


Avaliar a trajetória das taxas de mortalidade por COVID-19 no Brasil e comparar as taxas extremas de 2022 e de 2021, em distintos grupos etários. Estudo ecológico com óbitos por síndrome respiratória aguda grave por COVID-19, tendo o Brasil como unidade de análise. Os dados foram obtidos do Sistema de Informação da Vigilância Epidemiológica da Gripe. Foram avaliados os óbitos no período de 10 de janeiro de 2021 a 12 de fevereiro de 2022, agrupado em Semanas Epidemiológicas (SE). A análise dos dados foi conduzida no software R, utilizando modelos Poisson para estimar as taxas de mortalidade. O nível de significância estatística foi 5%. Foram avaliados 408.180 óbitos, sendo 0,34% de indivíduos menores de18 anos e 64,6% daqueles com 60 anos e mais. De um lado, nas faixas etárias de 0-1, 2-4 e 5-11 anos, observaram-se maiores taxas de mortalidade nas SE 4-6/2022, em comparação às maiores de 2021. De outro, nos indivíduos de 12-17 anos, estimou-se taxa inferior no grupo de SE 4-6/2022, em comparação ao grupo de SE 11-13 de 2021, com razão de mortalidade 0,60 (IC95%: 0,38-0,94). Detectaram-se padrões opostos na mortalidade por COVID-19 no Brasil entre crianças e indivíduos incluídos na campanha nacional de vacinação. Entre os primeiros, observaram-se taxas de mortalidade iguais ou piores do que em fases anteriores da epidemia, contrapondo-se ao registro de queda consistente e forte dos últimos, reforçando a efetividade da vacina contra COVID-19.


Los objetivos fueron evaluar la trayectoria de las tasas de mortalidad por COVID-19 en Brasil y comparar las tasas extremas del 2022 y del 2021, en diferentes grupos de edad. Estudio ecológico con muertes por síndrome respiratorio agudo Severo por COVID-19, teniendo a Brasil como unidad de análisis. Los datos se obtuvieron del Sistema de Información de Vigilancia Epidemiológica de la Gripe. Se evaluaron las defunciones del 10 de enero del 2021 al 12 de febrero del 2022, agrupadas en Semanas Epidemiológicas (SE). El análisis de datos se realizó en el software R, utilizando modelos Poisson para estimar las tasas de mortalidad. El nivel de significancia estadística fue del 5%. Se evaluaron un total de 408.180 defunciones, el 0,34% fue de individuos menores de 18 años y el 64,6% fue de individuos con 60 años o más. Por una parte, en los rangos de edad 0-1, 2-4 y 5-11 se observaron mayores tasas de mortalidad en SE 4-6/2022, en comparación con las más altas del 2021. Por otra parte, en los individuos de 12-17 años se estimó una tasa inferior en el grupo SE 4-6/2022, en comparación con el grupo de SE 11-13 del 2021, con una razón de mortalidad de 0,60 (IC95%: 0,38-0,94). Se detectaron estándares opuestos en la mortalidad por COVID-19 en Brasil entre niños e individuos incluidos en la campaña nacional de vacunación. Entre los primeros, se observaron tasas de mortalidad iguales o peores que en etapas anteriores de la epidemia, en contraste con el registro de una reducción consistente y fuerte de los últimos, lo que reforzó la efectividad de la vacuna contra la COVID-19.


Subject(s)
COVID-19 , Influenza Vaccines , Influenza, Human , Adolescent , Brazil/epidemiology , COVID-19 Vaccines , Child , Humans , Middle Aged , Mortality
3.
Int J Soc Psychiatry ; 68(5): 997-1009, 2022 08.
Article in English | MEDLINE | ID: covidwho-1868857

ABSTRACT

BACKGROUND: The COVID-19 pandemic has already claimed more than six million direct deaths. Low-and middle-income countries, such Brazil, were severely hit, not only due to direct effects on mortality, but also for its indirect effects on other causes of deaths. AIMS: The objective of this study was to estimate the excess suicides in Brazil and evaluate patterns within and between its regions during the COVID-19 pandemic in 2020. METHOD: The observed suicides are gathered from the mortality information system of the Brazilian Ministry of Health. The estimates of expected suicides, according to sex, age group, bimonthly period and region, were reached through quasi-Poisson generalized additive models, with adjustment for overdispersion. The analyses were performed in R software, version 3.6.1 and RStudio, version 1.2.1335. RESULTS: From March 2020 to December 2020, 10,409 suicides were observed in Brazil, resulting in an overall decrease of 13%, in comparison to the expected rate for the period. There were excess suicides of 26% in men from the Northern region in the 60 years and more age group, as well as in women from the Northern region in the 30 to 59 years age group in two consecutive bimonthly periods. Excess suicides of 40% was also observed in women in the 60 years and more age group from the Northeastern region. CONCLUSIONS: Despite the overall decrease in suicides in Brazil over the period assessed, substantial excess suicides were observed in different age groups and sexes from the Northern and Northeastern regions of the country, which are regions that are historically more prone to health and socioeconomic inequalities.


Subject(s)
COVID-19 , Suicide , Adult , Brazil/epidemiology , COVID-19/epidemiology , Female , Humans , Income , Male , Middle Aged , Pandemics
4.
Cad Saude Publica ; 38(5): PT192321, 2022.
Article in Portuguese | MEDLINE | ID: covidwho-1855089

ABSTRACT

The impact of COVID-19 vaccination in the elderly has received relatively little attention, particularly in a scenario predominated by the gamma variant. The aim of this study was to assess vaccination coverage and its relationship to changes in the pattern of COVID-19 hospitalizations and deaths in the elderly in Manaus, Amazonas State, Brazil. This was an ecological study with Brazilian Ministry of Health data on hospitalizations and deaths, assessing vaccination coverage based on a two-dose regimen, in addition to two vaccination regimens associated with a significant protective effect, one partial (35 days or more after the first dose of the Oxford/AstraZeneca vaccine) and the other complete (14 days or more after the second dose of the Sinovac-CoronaVac vaccine). Based on the date of initial symptoms, patterns of COVID-19 hospitalizations and deaths were assessed comparatively in elderly 60-69 years and 70 years or more in two groups of Epidemiological Weeks (EW) in 2020 (unvaccinated) and 2021 (vaccinated). Hospitalization and death rates were estimated with Poisson regression. In the groups 60-69 and 70 years or more, vaccination coverage rates were 41.8% and 54.8%, as well as 53.5% and 90.1%, in the EW groups 18-20/2021 and 21-23/2021, respectively. Both EW groups in 2021 showed a substantial change in the patterns of COVID-19 hospitalizations and deaths, with an increase in the risk of hospitalization and death in unvaccinated younger individuals and an important reduction in vaccinated elderly, especially those 60-69 years of age, besides overall reductions of 62% (95%CI: 52-69) and 63% (95%CI: 43-75) in hospitalization and death rates, respectively. Our results emphasize the importance of mass vaccination, especially during an epidemic such as in Manaus, marked by high circulation of the gamma variant.


A avaliação do impacto da vacinação contra a COVID-19 em idosos é escassa, sobretudo em um cenário com predomínio da variante Gama. O objetivo deste estudo foi avaliar a cobertura vacinal e sua relação com mudanças no padrão de internações e óbitos por COVID-19 em idosos de Manaus, Amazonas, Brasil. Este é um estudo ecológico com dados de internações e óbitos do Ministério da Saúde que avaliou a cobertura vacinal, mediante esquema com duas doses, além de dois regimes de vacinação associados a significativo efeito protetor, um parcial (35 ou mais dias após a primeira dose da vacina Oxford/AstraZeneca) e outro completo (14 dias ou mais após a segunda dose da vacina Sinovac-CoronaVac). A partir da data dos primeiros sintomas, padrões de internação e óbito por COVID-19 foram avaliados, comparativamente, em idosos de 60-69 e de 70 anos ou mais, em dois grupos de Semanas Epidemiológicas (SE) de 2020 (não vacinados) e 2021 (vacinados). Taxas de internação e óbito foram estimadas pelo modelo Poisson. Entre 60-69 anos e naqueles com 70 anos ou mais, a cobertura por vacina foi 41,8% e 54,8%, bem como 53,5% e 90,1% nos grupos de SE 18-20/2021 e 21-23/2021, respectivamente. Em ambos os grupos de SE de 2021, observou-se substancial mudança nos padrões de internações e óbitos por COVID-19, com aumento no risco de internação e óbito nos mais jovens não vacinados, e importante redução no número de idosos vacinados, sobretudo naqueles com 60-69 anos, além de redução global de 62% (IC95%: 52-69) e 63% (IC95%: 43-75) nas taxas de internação e óbitos, respectivamente. Nossos resultados reforçam a importância da vacinação em massa, especialmente em contexto epidêmico como o de Manaus, marcado por elevada circulação da variante Gama.


La evaluación del impacto de la vacunación contra la COVID-19 en ancianos es escasa, sobre todo en un escenario con predominio de la variante Gamma. El objetivo de este estudio fue evaluar la cobertura de vacunación y su relación con cambios en el patrón de internamientos y óbitos por COVID-19 en ancianos de Manaos, Amazonas, Brasil. Este es un estudio ecológico con datos de internamientos y óbitos del Ministerio de Salud, que evaluó la cobertura de vacunación, mediante un esquema con dos dosis, además de dos regímenes de vacunación, asociados a un significativo efecto protector, uno parcial (35 o más días tras la primera dosis de la vacuna Oxford/AstraZeneca) y otro completo (14 días o más tras la segunda dosis de la vacuna Sinovac-CoronaVac). A partir de los datos de los primeros síntomas, se evaluaron patrones de internamiento y óbito por COVID-19, comparativamente, en ancianos de 60-69 y de 70 años o más, en dos grupos de Semanas Epidemiológicas (SE) de 2020 (no vacunados) y 2021 (vacunados). Se estimaron tasas de internamiento y óbito mediante el modelo Poisson. Entre 60-69 años y en aquellos con 70 años o más, la cobertura por vacuna fue 41,8% y 54,8%, así como 53,5% y 90,1% en los grupos de SE 18-20/2021 y 21-23/2021, respectivamente. En ambos grupos de SE de 2021, se observó un cambio sustancial en los patrones de internamiento y óbitos por COVID-19, con un aumento en el riesgo de internamiento y óbito en los más jóvenes no vacunados e importante reducción en los ancianos vacunados, sobre todo en aquellos con 60-69 años, además de una reducción global de 62% (IC95%: 52-69) y 63% (IC95%: 43-75) en las tasas de internamiento y óbitos, respectivamente. Nuestros resultados refuerzan la importancia de la vacunación en masa, especialmente en un contexto epidémico como el de Manaos, marcado por una elevada circulación de la variante Gamma.


Subject(s)
COVID-19 , Vaccines , Aged , Brazil/epidemiology , COVID-19/prevention & control , COVID-19 Vaccines , Hospitalization , Humans , SARS-CoV-2 , Vaccination
5.
Epidemiol Serv Saude ; 30(4): e2021709, 2021.
Article in Portuguese, English | MEDLINE | ID: covidwho-1547052

ABSTRACT

OBJECTIVE: To describe in-hospital and intensive care unit (ICU) case fatality ratios due to COVID-19 in four Brazilian state capitals, during the months of epidemic peaks and previous months. METHODS: This was an ecological study using monthly data from the Influenza Epidemiological Surveillance Information System, between 2020-2021, in individuals aged 20 years or older. Case fatality ratio and mortality rate were estimated with 95% confidence intervals (95%CI). RESULTS: In Manaus, the capital city of the state of Amazonas, ICU case fatality ratio among those >59 years old was lower in December/2020 (80.9%; 95%CI 78.4;83.3) and during the peak in January/2021 (79.9%; 95%CI 77.4;82.5), compared to the peak in April/2020 (88.2%; 95%CI 86.1;90.3). In São Paulo, the capital city of the state of São Paulo, Curitiba, the capital city of the state of Paraná, and Porto Alegre, the capital city of the state of Rio Grande do Sul, there was a decrease or stability in ICU and in-hospital case fatality ratio in January/2021, compared to the reference month in 2020. CONCLUSION: In January/2021, in-hospital and ICU case fatality ratios decreased or remained stable in the four state capitals, especially in Manaus, and during the epidemic peak with the prevalence of the Gamma variant.


Subject(s)
COVID-19 , Brazil/epidemiology , Hospitals , Humans , Middle Aged , SARS-CoV-2
6.
Int J Environ Res Public Health ; 18(17)2021 08 30.
Article in English | MEDLINE | ID: covidwho-1403586

ABSTRACT

To describe the factors associated to stunting in <5-year-old Yanomami Brazilian children, and to evaluate the association of short maternal stature to their offspring's stunting. A cross-sectional study carried out in three villages in the Yanomami territory. We performed a census, in which all households with children < 5-years-old were included. The length/height-for-age z-score <-2 standard deviations was used to classify the children as stunted. Short maternal height was defined as <145 cm for adult women, and <-2 standard deviations of the height-for-age z-score for adolescent women. We used adjusted Poisson regression models to estimate prevalence ratios (PR) along the 90% confidence interval. We evaluated 298 children. 81.2% of children suffered from stunting and 71.9% of the mothers from short stature. In the bivariate analysis, a significant association of stunting with short maternal stature, gestational malaria and child's place of birth were observed. Considering the variables of the children under five years of age, there were significant associations with age group, the child's caregiver, history of malaria, pneumonia, and malnutrition treatment. In the adjusted hierarchical model, stunting was 1.22 times greater in the offspring of women with a short stature (90% CI: 1.07-1.38) compared to their counterparts. Brazilian Amazonian indigenous children living in a remote area displayed an alarming prevalence of stunting, and this was associated with short maternal height, reinforcing the hypothesis of intergenerational chronic malnutrition transmission in this population. In addition, children above 24 months of age, who were born in the village healthcare units and who had had previous treatment in the past for stunting presented higher rates of stunting in this study.


Subject(s)
Growth Disorders , Malnutrition , Adolescent , Child , Child, Preschool , Cross-Sectional Studies , Family Characteristics , Female , Growth Disorders/epidemiology , Humans , Infant , Mothers , Prevalence , Socioeconomic Factors
7.
Cad. Saúde Pública (Online) ; 36(7):e00120020-e00120020, 2020.
Article in Portuguese | LILACS (Americas) | ID: grc-741614

ABSTRACT

Manaus, capital do estado brasileiro do Amazonas, é o atual epicentro da epidemia na Amazônia com um aumento repentino de mortes que preocupa gestores e sociedade. O objetivo do estudo foi analisar o excesso na mortalidade geral, segundo Semanas Epidemiológicas (SE), visando a identificar mudanças potencialmente associadas à epidemia em Manaus. Dados de mortalidade geral e grupos de causas foram obtidos na Central de Informações do Registro Civil Nacional e no Sistema de Informações sobre Mortalidade, para 2018, 2019 e 2020. Analisou-se faixa etária, sexo, local de ocorrência do óbito, SE, ano-calendário e causas de morte. Calcularam-se razões entre as mortes ocorridas em 2019/2018 e 2020/2019 para avaliar o excesso de mortes, com intervalos de confiança no nível de 5%. Não observou-se excesso de mortalidade geral significativo nas razões 2019/2018, independentemente da SE. Já as razões de 2020/2019 passaram de 1,0 (IC95%: 0,9-1,3) na SE 12 para 4,6 (IC95%: 3,9-5,3) na SE 17. Observou-se excesso de mortalidade geral com a progressão da idade, especialmente em indivíduos com 60 anos e mais, os quais concentraram 69,1% (IC95%: 66,8-71,4) das mortes. A razão 2020/2019 para óbitos em domicílio/via pública foi de 1,1 (IC95%: 0,7-1,8) na SE 12 e de 7,8 (IC95%: 5,4-11,2) na SE 17. A explosão da mortalidade geral em Manaus e a elevada proporção de óbitos em domicílio/via pública expõe a gravidade da epidemia em contextos de grande desigualdade social e fraca efetividade de ações governamentais, em especial aquelas voltadas ao enfrentamento das desigualdades sociais e para a garantia e fortalecimento do Sistema Único de Saúde. Manaus, capital del estado brasileño del Amazonas, es el actual epicentro de la epidemia en Amazonia y el aumento repentino de muertes preocupa a gestores y a la sociedad. El objetivo del estudio fue analizar el exceso en la mortalidad general, según Semanas Epidemiológicas (SE), con el objetivo de identificar cambios potencialmente asociados a la epidemia en Manaus. Los datos de mortalidad general y grupos de causas se obtuvieron en la Central de Información del Registro Civil Nacional y en el Sistema de Información sobre Mortalidad, referentes a 2018, 2019 y 2020. Se analizó franja de edad, sexo, lugar donde se produjo el fallecimiento, SE, año-calendario y causas de muerte. Se calcularon las causas entre las muertes acaecidas en 2019/2018 y 2020/2019 para evaluar el exceso de muertes, con intervalos de confianza en el nivel de 5%. No se observó un exceso de mortalidad general significativo en las causas 2019/2018, independientemente de la SE. Ya las causas de 2020/2019 pasaron de 1,0 (IC95%: 0,9-1,3) en la SE 12 a 4,6 (IC95%: 3,9-5,3) en la SE 17. Se observó un exceso de mortalidad general con la progresión de la edad, especialmente en individuos con 60 años y más, quienes concentraron un 69,1% (IC95%: 66,8-71,4) de las muertes. La razón 2020/2019 para óbitos en domicilio/vía pública fue de 1,1 (IC95%: 0,7-1,8) en la SE 12 y de 7,8 (IC95%: 5,4-11,2) en la SE 17. La explosión de la mortalidad general en Manaus y la elevada proporción de óbitos en domicilio/vía pública expone la gravedad de la epidemia en contextos de gran desigualdad social y débil efectividad de las acciones gubernamentales, en especial aquellas dirigidas al combate de las desigualdades sociales y para la garantía y fortalecimiento del Sistema Único de Salud. Manaus, the capital of the Brazilian State of Amazonas, is the current epicenter of the COVID-19 epidemic in Amazonia. The sharp increase in deaths is a huge concern for health system administrators and society. The study aimed to analyze excess overall mortality according to Epidemiological Week (EW) in order to identify changes potentially associated with the epidemic in Manaus. Overall and cause-specific mortality data were obtained from the Central Database of the National Civil Registry and the Mortality Information System for 2018, 2019, and 2020. The study analyzed age bracket, sex, place of death, EW, calendar year, and causes of death. Ratios were calculated between deaths in 2019/2018 and 2020/2019 to estimate excess deaths, with 5% confidence intervals. No significant excess overall mortality was seen in the ratios for 2019/2018, independently of EW. Meanwhile, the ratios for 2020/2019 increased from 1.0 (95%CI: 0.9-1.3) in EW 11 to 4.6 (95%CI: 3.9-5.3) in EW 17. Excess overall mortality was observed with increasing age, especially in individuals 60 years or older, who accounted for 69.1% (95%CI: 66.8-71.4) of the deaths. The ratios for 2020/2019 for deaths at home or on public byways were 1.1 (95%CI: 0.7-1.8) in EW 12 and 7.8 (95%CI: 5.4-11.2) in EW 17. The explosion in overall mortality in Manaus and the high proportion of deaths at home or on public byways reveals the epidemic's severity in contexts of heavy social inequality and weak effectiveness of government policies, especially policies meant to deal with social inequalities and strengthen the Unified Health System.

8.
Cad Saude Publica ; 36(7): e00120020, 2020.
Article in English, Portuguese | MEDLINE | ID: covidwho-636860

ABSTRACT

Manaus, the capital of the Brazilian State of Amazonas, is the current epicenter of the COVID-19 epidemic in Amazonia. The sharp increase in deaths is a huge concern for health system administrators and society. The study aimed to analyze excess overall mortality according to Epidemiological Week (EW) in order to identify changes potentially associated with the epidemic in Manaus. Overall and cause-specific mortality data were obtained from the Central Database of the National Civil Registry and the Mortality Information System for 2018, 2019, and 2020. The study analyzed age bracket, sex, place of death, EW, calendar year, and causes of death. Ratios were calculated between deaths in 2019/2018 and 2020/2019 to estimate excess deaths, with 5% confidence intervals. No significant excess overall mortality was seen in the ratios for 2019/2018, independently of EW. Meanwhile, the ratios for 2020/2019 increased from 1.0 (95%CI: 0.9-1.3) in EW 11 to 4.6 (95%CI: 3.9-5.3) in EW 17. Excess overall mortality was observed with increasing age, especially in individuals 60 years or older, who accounted for 69.1% (95%CI: 66.8-71.4) of the deaths. The ratios for 2020/2019 for deaths at home or on public byways were 1.1 (95%CI: 0.7-1.8) in EW 12 and 7.8 (95%CI: 5.4-11.2) in EW 17. The explosion in overall mortality in Manaus and the high proportion of deaths at home or on public byways reveals the epidemic's severity in contexts of heavy social inequality and weak effectiveness of government policies, especially policies meant to deal with social inequalities and strengthen the Unified Health System.


Subject(s)
Coronavirus Infections/epidemiology , Mortality/trends , Pneumonia, Viral/epidemiology , Public Health Surveillance/methods , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Betacoronavirus , Brazil/epidemiology , COVID-19 , Cause of Death , Child , Child, Preschool , Coronavirus Infections/mortality , Cross-Sectional Studies , Humans , Infant , Infant, Newborn , Middle Aged , Pandemics , Pneumonia, Viral/mortality , SARS-CoV-2 , Sex Distribution , Vulnerable Populations , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL